BAM
GERM

Belpointe Asset Management’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History

Belpointe Asset Management’s Portfolio GERM Stock Details GERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,783
Closed -$36.5K – 3615
2023
Q1 		$36.5K Sell
1,783
-1,660
-48% -$33.9K ﹤0.01% 1913
2022
Q4 		$77.1K Buy
+3,443
New +$77.1K ﹤0.01% 1383